BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26926953)

  • 1. Establishment and characterisation of patient-derived xenografts as paraclinical models for gastric cancer.
    Choi YY; Lee JE; Kim H; Sim MH; Kim KK; Lee G; Kim HI; An JY; Hyung WJ; Kim CB; Noh SH; Kim S; Cheong JH
    Sci Rep; 2016 Mar; 6():22172. PubMed ID: 26926953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of Novel Gastric Cancer Patient-Derived Xenografts and Cell Lines: Pathological Comparison between Primary Tumor, Patient-Derived, and Cell-Line Derived Xenografts.
    Kuwata T; Yanagihara K; Iino Y; Komatsu T; Ochiai A; Sekine S; Taniguchi H; Katai H; Kinoshita T; Ohtsu A
    Cells; 2019 Jun; 8(6):. PubMed ID: 31207870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and preclinical application of a patient-derived xenograft model for uterine cancer.
    Jeong SY; Cho YJ; Ryu JY; Choi JJ; Hwang JR; Kim B; Lee YY; Kim HS; Lee JW
    Gynecol Oncol; 2021 Jul; 162(1):173-181. PubMed ID: 33972086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Derived Gastric Carcinoma Xenograft Mouse Models Faithfully Represent Human Tumor Molecular Diversity.
    Zhang T; Zhang L; Fan S; Zhang M; Fu H; Liu Y; Yin X; Chen H; Xie L; Zhang J; Gavine PR; Gu Y; Ni X; Su X
    PLoS One; 2015; 10(7):e0134493. PubMed ID: 26217940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Derived Xenografts Can Be Reliably Generated from Patient Clinical Biopsy Specimens.
    Hernandez MC; Bergquist JR; Leiting JL; Ivanics T; Yang L; Smoot RL; Nagorney DM; Truty MJ
    J Gastrointest Surg; 2019 Apr; 23(4):818-824. PubMed ID: 30756315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and characterization of a non-gestational choriocarcinoma patient-derived xenograft model.
    Oda Y; Niimi K; Yoshida K; Tamauchi S; Yokoi A; Yasui Y; Nishiko Y; Shibata M; Shimizu Y; Yoshihara M; Ikeda Y; Yoshikawa N; Nishino K; Yamamoto E; Kajiyama H
    BMC Cancer; 2023 Nov; 23(1):1103. PubMed ID: 37957624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a high-fidelity patient-derived xenograft model for cervical cancer enables the evaluation of patient's response to conventional and novel therapies.
    Liu L; Wu M; Huang A; Gao C; Yang Y; Liu H; Jiang H; Yu L; Huang Y; Wang H
    J Transl Med; 2023 Sep; 21(1):611. PubMed ID: 37689699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population.
    Karalis JD; Yoon LY; Hammer STG; Hong C; Zhu M; Nassour I; Ju MR; Xiao S; Castro-Dubon EC; Agrawal D; Suarez J; Reznik SI; Mansour JC; Polanco PM; Yopp AC; Zeh HJ; Hwang TH; Zhu H; Porembka MR; Wang SC
    J Transl Med; 2022 Mar; 20(1):116. PubMed ID: 35255940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of molecular subtypes and clonal selection during establishment of patient-derived tumor xenografts from gastric adenocarcinoma.
    Peille AL; Vuaroqueaux V; Wong SS; Ting J; Klingner K; Zeitouni B; Landesfeind M; Kim WH; Lee HJ; Kong SH; Wulur I; Bray S; Bronsert P; Zanella N; Donoho G; Yang HK; Fiebig HH; Reinhard C; Aggarwal A
    Commun Biol; 2020 Jul; 3(1):367. PubMed ID: 32647357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of patient-derived cancer xenografts in immunodeficient NOG mice.
    Chijiwa T; Kawai K; Noguchi A; Sato H; Hayashi A; Cho H; Shiozawa M; Kishida T; Morinaga S; Yokose T; Katayama M; Takenaka N; Suemizu H; Yamada R; Nakamura Y; Ohtsu T; Takano Y; Imai K; Miyagi Y; Nakamura M
    Int J Oncol; 2015 Jul; 47(1):61-70. PubMed ID: 25963555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and genetically characterization of patient-derived xenograft models of cervical cancer.
    Zou S; Ye M; Zhang JA; Ji H; Chen Y; Zhu X
    BMC Med Genomics; 2022 Sep; 15(1):191. PubMed ID: 36076209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of melanoma patient-derived xenograft models for preclinical evaluation of novel therapeutics.
    Yan J; Wu X; Yu J; Ma M; Yu H; Xu T; Tang H; Xu L; Dai J; Si L; Chi Z; Sheng X; Cui C; Guo J; Kong Y
    Melanoma Res; 2018 Dec; 28(6):527-535. PubMed ID: 30086074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps.
    Ilie M; Nunes M; Blot L; Hofman V; Long-Mira E; Butori C; Selva E; Merino-Trigo A; Vénissac N; Mouroux J; Vrignaud P; Hofman P
    Cancer Med; 2015 Feb; 4(2):201-11. PubMed ID: 25470237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy.
    Pan CX; Zhang H; Tepper CG; Lin TY; Davis RR; Keck J; Ghosh PM; Gill P; Airhart S; Bult C; Gandara DR; Liu E; de Vere White RW
    PLoS One; 2015; 10(8):e0134346. PubMed ID: 26270481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models.
    Hynds RE; Huebner A; Pearce DR; Hill MS; Akarca AU; Moore DA; Ward S; Gowers KHC; Karasaki T; Al Bakir M; Wilson GA; Pich O; Martínez-Ruiz C; Hossain ASMM; Pearce SP; Sivakumar M; Ben Aissa A; Grönroos E; Chandrasekharan D; Kolluri KK; Towns R; Wang K; Cook DE; Bosshard-Carter L; Naceur-Lombardelli C; Rowan AJ; Veeriah S; Litchfield K; Crosbie PAJ; Dive C; Quezada SA; Janes SM; Jamal-Hanjani M; Marafioti T; ; McGranahan N; Swanton C
    Nat Commun; 2024 May; 15(1):4653. PubMed ID: 38821942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and characterization of patient-derived tumor xenograft using gastroscopic biopsies in gastric cancer.
    Zhu Y; Tian T; Li Z; Tang Z; Wang L; Wu J; Li Y; Dong B; Li Y; Li N; Zou J; Gao J; Shen L
    Sci Rep; 2015 Feb; 5():8542. PubMed ID: 25712750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of Murine Stroma and Selective Purification of the Human Tumor Component of Patient-Derived Xenografts for Genomic Analysis.
    Schneeberger VE; Allaj V; Gardner EE; Poirier JT; Rudin CM
    PLoS One; 2016; 11(9):e0160587. PubMed ID: 27611664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in Stratifying the Molecular Variability of Patient-Derived Colon Tumor Xenografts.
    Cybulska M; Olesinski T; Goryca K; Paczkowska K; Statkiewicz M; Kopczynski M; Grochowska A; Unrug-Bielawska K; Tyl-Bielicka A; Gajewska M; Mroz A; Dabrowska M; Karczmarski J; Paziewska A; Zając L; Bednarczyk M; Mikula M; Ostrowski J
    Biomed Res Int; 2018; 2018():2954208. PubMed ID: 30662905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines.
    Lu JH; Wang Y; Meng Q; Zeng ZL
    J Vis Exp; 2019 Jul; (149):. PubMed ID: 31380849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-Derived Bladder Cancer Xenografts.
    Bernardo C; Santos LL
    Methods Mol Biol; 2018; 1655():169-175. PubMed ID: 28889386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.